Painful Hiv-Associated Sensory Neuropathy

• Ellis R , RosarioD, CliffordD et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch. Neurol. 67(5) , 552–558 (2010).
   PubMedGoogle Scholar
• Wadley A , CherryC, PriceP, KamermanP. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J. Pain Symptom. Manage.41(4) , 700–706 (2010).
   PubMed Web of Science ®Google Scholar
• Smyth K , AffandiJ, McarthurJ et al. Prevalence and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993–2006. HIV Med. 8(6) , 367–373 (2007).
   PubMed Web of Science ®Google Scholar
• Cherry C , SkolaskyR, LalL et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology 66(6) , 867–873 (2006).
   PubMed Web of Science ®Google Scholar
• Maritz J , BenatarM, DaveJ et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve 41(5) , 599–606 (2010).
   PubMed Web of Science ®Google Scholar
• Hitchcock S , MeyerH, GwytherE. Neuropathic pain in AIDS patients prior to antiretroviral therapy. S. Afr. Med. J.98(11) , 889–892 (2008).
   PubMed Web of Science ®Google Scholar
• Doth A , HanssonP, JensenM, TaylorR. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain149(2) , 338–344 (2010).
   PubMed Web of Science ®Google Scholar
• Meyer-Rosberg K , KvarnströmA, KinnmanE, GordhT, NordforsL, KristoffersonA. Peripheral neuropathic pain – a multidimensional burden for patients. Eur. J. Pain5(4) , 379–389 (2001).
   PubMed Web of Science ®Google Scholar
• Phillips T , CherryC, CoxS, MarshallS, RiceA. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE5(12) , e14433 (2010).
   PubMed Web of Science ®Google Scholar
• Kamerman P , WadleyA, CherryC. HIV-associated sensory neuropathy: risk factors and genetics. Curr. Pain Headache Rep.16(3) , 226–236 (2012).
   PubMed Web of Science ®Google Scholar
• Barohn R , GronsethG, LeforceB et al. Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch. Neurol. 50 , 167–170 (1993).
   PubMedGoogle Scholar
• Woolley I , FaragherM, UgoniA, SpelmanD. An analysis of factors associated with HIV-related peripheral neuropathy. Neurol. Infect. Epidemiol.1997(2) , 33–37 (1997).
   Google Scholar
• Childs E , LylesR, SelnesO et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52 , 607–613 (1999).
   PubMed Web of Science ®Google Scholar
• So Y , HoltzmanD, AbramsD, OlneyR. Peripheral neuropathy associated with acquired immunodeficiency syndrome – prevalence and clinical features from a population-based survey. Arch. Neurol.45 , 945–948 (1988).
   PubMed Web of Science ®Google Scholar
• Evans S , EllisR, ChenH et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS 25(7) , 919–928 (2011).
   PubMed Web of Science ®Google Scholar
• Menezes C , MaskewM, SanneI, CrowtherN, RaalF. A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects. BMC Infect. Dis.11(244) , 1–10 (2011).
   PubMedGoogle Scholar
• Shurie J , DeribewA. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals. Ethiop. Med. J.48(2) , 85–93 (2010).
   PubMedGoogle Scholar
• Cherry C , AffandiJ, ImranD et al. Age and height predict neuropathy risk in HIV patients prescribed stavudine. Neurology 73(4) , 315–320 (2009).
   PubMed Web of Science ®Google Scholar
• Wright E , BrewB, ArayawichanontA et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 71(1) , 50–56 (2008).
   PubMed Web of Science ®Google Scholar
• Forna F , LiechtyC, SolbergP et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS Care program in rural Uganda. J. Acquir. Immune Defic. Syndr. 44(4) , 456–462 (2007).
   PubMed Web of Science ®Google Scholar
• Sacktor N , NakasujjaN, SkolaskyR et al. Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda. Neurology 72(2) , 165–170 (2009).
   PubMed Web of Science ®Google Scholar
• Brinkman K , SmeitinkJ, RomijnJ, ReissP. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet354(9184) , 1112–1115 (1999).
   PubMed Web of Science ®Google Scholar
• Brinkman K , TerHofstedeJ, BurgerD, SmeitinkJ, KoopmansP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS12 , 1735–1744 (1998).
   PubMed Web of Science ®Google Scholar
• Lewis W , DalakasM. Mitochondrial toxicity of antiviral drugs. Nature Med.1 , 417–422 (1995).
   PubMed Web of Science ®Google Scholar
• Kakuda T . Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin. Ther.22 , 685–708 (2000).
   PubMed Web of Science ®Google Scholar
• Cherry C , McarthurJ, HoyJ, WesselinghS. Nucleoside analogues and neuropathy in the era of HAART. J. Clin. Virol.26(2) , 195–207 (2003).
   PubMed Web of Science ®Google Scholar
• Canter J , HaasD, KallianpurA et al. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics J. 8(1) , 71–77 (2008).
   PubMed Web of Science ®Google Scholar
• Hulgan T , HaasD, HainesJ et al. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19(13) , 1341–1349 (2005).
   PubMed Web of Science ®Google Scholar
• Canter J , RobbinsG, SelphD et al. African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy. J. Infect. Dis. 201(11) , 1703–1707 (2010).
   PubMed Web of Science ®Google Scholar
• Kallianpur A , HulganT, CanterJ et al. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 20(11) , 1503–1513 (2006).
   PubMed Web of Science ®Google Scholar
• Chen X , GoudsmitJ, Van Der Kuyl A. Lack of correlation between length variation in the DNA polymerase gamma gene CAG repeat and lactic acidosis or neuropathy during antiretroviral treatment. AIDS Res. Hum. Retroviruses18(8) , 531–534 (2002).
   PubMed Web of Science ®Google Scholar
• Chan S , CopelandW. DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. Biochem. Biophys. Acta1787(5) , 312–319 (2009).
   PubMed Web of Science ®Google Scholar
• Nakamoto B , McmurtrayA, DavisJ et al. Incident neuropathy in HIV-infected patients on HAART. AIDS Res. Hum. Retrovirus 26(7) , 759–765 (2010).
   PubMed Web of Science ®Google Scholar
• Anziska Y , HelznerE, CrystalH et al. The relationship between race and HIV-distal sensory polyneuropathy in a large cohort of US women. J. Neurol. Sci. 315(1–2) , 129–132 (2012).
   PubMed Web of Science ®Google Scholar
• Ances B , VaidaF, RosarioD et al. Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS 23(17) , 2317–2322 (2009).
   PubMed Web of Science ®Google Scholar
• Cherry C , AffandiJ, BrewB et al. Ethnicity is an independent predictor of neuropathy risk in HIV patients. Presented at: 18th Conference on Retroviruses and Opportunistic Infections. MA, USA, 27 February–2 March 2011.
   Google Scholar
• Robinson-Papp J , MorgelloS, VaidaF et al. Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain 151(3) , 732–736 (2010).
   PubMed Web of Science ®Google Scholar
• Pettersen J , JonesG, WorthingtonC et al. Sensory neuropathy in human immunodeficiency virus / acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann. Neurol. 59(5) , 816–824 (2006).
   PubMed Web of Science ®Google Scholar
• Lichtenstein K , ArmonC, BaronA et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin. Infect. Dis. 40(1) , 148–157 (2005).
   PubMed Web of Science ®Google Scholar
• Ellis R , Marquie-BeckJ, DelaneyP et al. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann. Neurol. 64(5) , 566–572 (2008).
   PubMed Web of Science ®Google Scholar
• Nagano I , ShapshakP, YoshiokaM, XinK, NakamuraS, BradleyW. Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome. J. Neurol. Sci.136(1–2) , 117–128 (1996).
   PubMed Web of Science ®Google Scholar
• Wesselingh S , GlassJ, McarthurJ, GriffinJ, GriffinD. Cytokine dysregulation in HIV-associated neurological disease. Advance Neuroimmunol.4 , 199–206 (1994).
   PubMedGoogle Scholar
• Tyor W , WesselinghS, GriffinJ, McarthurJ, GriffinD. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.9(4) , 379–388 (1995).
   PubMedGoogle Scholar
• Cherry C , AffandiJ, RosenowA, McarthurJ, WesselinghS, PriceP. Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual‘s NRTI-SN risk. AIDS Res. Hum. Retroviruses24(2) , 117–123 (2008).
   PubMed Web of Science ®Google Scholar
• Affandi J , PriceP, ImranD, YuhaningsihE, DjauziS, CherryC. Can we predict neuropathy risk before stavudine prescription in a resource limited setting? AIDS Res. Hum. Retroviruses24(10) , 1281–1284 (2008).
   PubMed Web of Science ®Google Scholar
• Chew C , CherryC, KamarulzamanA, YienT, AghafarZ, PriceP. A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patients. Dis. Markers31(5) , 303–309 (2011).
   PubMed Web of Science ®Google Scholar
• Attal N , Lanteri-MinetM, LaurentB, FermanianJ, BouhassiraD. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain152(12) , 2836–2843 (2011).
   PubMed Web of Science ®Google Scholar
• Lucey B , CliffordD, CreightonJ, EdwardsR, McarthurJ, HaythornthwaiteJ. Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy. AIDS Care23(8) , 921–928 (2011).
   PubMed Web of Science ®Google Scholar
• Evans S , WeinbergB, SpielmanL, FishmanB. Assessing negative thoughts in response to pain among people with HIV. Pain105(1–2) , 239–245 (2003).
   PubMed Web of Science ®Google Scholar
• Bouhassira D , AttalN, Willer J-C, Brasseur L. Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation. Pain80 , 265–273 (1999).
   PubMed Web of Science ®Google Scholar
• Martin C , SoldersG, SönnerborgA, HanssonP. Painful and non-painful neuropathy in HIV-infected patients: an analysis of somatosensory nerve function. Eur. J. Pain7(1) , 23–31 (2003).
   PubMed Web of Science ®Google Scholar
• Mcarthur J , GriffinJ. Another tool for the neurologist‘s toolbox. Ann. Neurol.57(2) , 163–167 (2005).
   PubMed Web of Science ®Google Scholar
• Mccarthy B , Hsieh S-T, Stocks A et al. Cutaneous innervation in sensory neuropathies: Evaluation by skin biopsy. Neurology45 , 1848–1855 (1995).
   PubMed Web of Science ®Google Scholar
• Simpson DM , HaidichAB, SchifittoG et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS 16 , 407–412 (2002).
   PubMed Web of Science ®Google Scholar
• Polydefkis M , YiannoutsosC, CohenB et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58(1) , 115–119 (2002).
   PubMed Web of Science ®Google Scholar
• Zhou L , KitchD, EvansS et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology 68(34) , 2113–2119 (2007).
   PubMedGoogle Scholar
• Wadley A , LombardZ, CherryC, PriceP, KamermanP. Analysis of a previously identified ‘pain protective‘ haplotype and individual polymorphisms in the GCH1 gene in Africans with HIV-associated sensory neuropathy: a genetic association study. J. Acquir. Immune Defic. Syndr.60(1) , 20–23 (2012).
   PubMed Web of Science ®Google Scholar
• Chew C , CherryC, ImranD et al. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients. Tissue Antigens 77(2) , 126–130 (2010).
   PubMedGoogle Scholar
• Rizzuto N , CavallaroT, ManacoS et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neruopathy. Acta Neuropathol. (Berlin) 90(3) , 244–250 (1995).
   PubMed Web of Science ®Google Scholar
• Bradley WG , ShapshakP, DelgadoS, NaganoI, StewartR, RochaB. Morphometric analysis of the peripheral neuropathy of AIDS. Muscle Nerve21 , 1188–1195 (1998).
   PubMed Web of Science ®Google Scholar
• Yoshioka M , ShapshakP, SrivastavaA et al. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 44(6) , 1120–1130 (1994).
   PubMed Web of Science ®Google Scholar
• Von Hehn C , BaronR, WoolfC. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron73(4) , 638–652 (2012).
   PubMed Web of Science ®Google Scholar
• Kamerman P , MossP, WeberJ, WallaceV, RiceA, HuangW. Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models. J. Peripher. Nerv. Syst.17(1) , 19–31 (2012).
   PubMed Web of Science ®Google Scholar
• Oh SB , TranPB, GillardSE, HurleyRW, HammondDL, MillerRJ. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci.21(14) , 5027–5035 (2001).
   PubMed Web of Science ®Google Scholar
• Acharjee S , NoorbakhshF, StemkowskiP et al. HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB J. 24(11) , 4343–4353 (2010).
   PubMed Web of Science ®Google Scholar
• Zheng W , OuyangH, ZhengX et al. Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol. Pain 7 , 40 (2011).
   PubMed Web of Science ®Google Scholar
• Bhangoo S , RipschM, BuchananD, MillerR, WhiteF. Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol. Pain5 , 48 (2009).
   PubMed Web of Science ®Google Scholar
• Wallace V , BlackbeardJ, PhebyT et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 133(1–3) , 47–63 (2007).
   PubMed Web of Science ®Google Scholar
• Wallace V , BlackbeardJ, SegerdahlA et al. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130(10) , 2688–2702 (2007).
   PubMedGoogle Scholar
• Herzberg U , SagenJ. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis. J. Neuroimmunol.116(1) , 29–39 (2001).
   PubMed Web of Science ®Google Scholar
• Joseph E , LevineJ. Caspase signalling in neuropathic and inflammatory pain in the rat. Eur. J. Neurosci.20(11) , 2896–2902 (2004).
   PubMed Web of Science ®Google Scholar
• Joseph E , LevineJ. Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain121(1–2) , 105–114 (2006).
   PubMed Web of Science ®Google Scholar
• Bhangoo S , RenD, MillerR et al. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav. Immun. 21(5) , 581–591 (2007).
   PubMed Web of Science ®Google Scholar
• Zheng X , OuyangH, LiuS, MataM, FinkD, HaoS. TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats. Brain Behav. Immun.25(8) , 1668–1676 (2011).
   PubMed Web of Science ®Google Scholar
• Renn C , LeitchC, LessansS et al. Brain-derived neurotrophic factor modulates antiretroviral-induced mechanical allodynia in the mouse. J. Neurosci. Res. 89(10) , 1551–1565 (2011).
   PubMed Web of Science ®Google Scholar
• Keswani S , JackC, ZhouC, HökeA. Establishment of a rodent model of HIV-associated sensory neuropathy. J. Neurosci.26(40) , 10299–10304 (2006).
   PubMed Web of Science ®Google Scholar
• Cherry C , AffandiJ, BrewB et al. Hepatitis C seropositivity is not a risk factor for sensory neuropathy among HIV patients. Neurology 74(19) , 1538–1542 (2010).
   PubMed Web of Science ®Google Scholar
• Gallant JE , StaszewskiS, Pozniak Al et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients. JAMA292(2) , 191–201 (2004).
   PubMed Web of Science ®Google Scholar
• Clifford D , SimpsonD, BrownS et al. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J. Acquir. Immune Defic. Syndr. 59(2) , 126–133 (2012).
   PubMed Web of Science ®Google Scholar
• Mills E , BakandaC, BirungiJ et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann. Intern. Med. 155(4) , 209–216 (2011).
   PubMed Web of Science ®Google Scholar
• van Sighem AI , GrasLA, ReissP, BrinkmanK, de Wolf F; ATHENA National Observational Cohort Study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS24(10) , 1527–1535 (2010).
   PubMed Web of Science ®Google Scholar
• Hahn K , TrioloA, HauerP, McarthurJ, PolydefkisM. Impaired reinnervation in HIV infection following experimental denervation. Neurology68(16) , 1251–1256 (2007).
   PubMed Web of Science ®Google Scholar
• Cherry C , WesselinghS, LalL, McarthurJ. Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology65(11) , 1778–1781 (2005).
   PubMed Web of Science ®Google Scholar
• Laast V , ShimB, JohanekL et al. Macrophage-mediated dorsal root ganglion damage precedes altered nerve conduction in SIV-infected macaques. Am. J. Pathol. 179(5) , 2337–2345 (2011).
   PubMed Web of Science ®Google Scholar

▪ Websites

• Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (2009). http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf (Accessed 3July2012)
   Google Scholar
• WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010 revision. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf (Accessed 3July2012)
   Google Scholar
• WHO. UNAIDS world AIDS day report (2011). www.who.int/hiv/data/en (Accessed 3July2012)
   Google Scholar